Nu Skin Enterprises, Inc.
General ticker "NUS" information:
- Sector: Consumer Staples
- Industry: Personal Care Products
- Capitalization: $419.9M (TTM average)
Nu Skin Enterprises, Inc. follows the US Stock Market performance with the rate: 56.4%.
Estimated limits based on current volatility of 1.8%: low 9.79$, high 10.15$
Factors to consider:
- Company pays dividends (quarterly): last record date 2025-08-29, amount 0.06$ (Y2.45%)
- Total employees count: 3100 as of 2024
- China accounted for 13.6% of revenue in the fiscal year ended 2024-12-31
- US accounted for 30.4% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Regulatory and compliance, Supply chain disruptions, Economic downturns and volatility, Market competition, Litigation risks
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [6.27$, 12.90$]
- 2025-12-31 to 2026-12-31 estimated range: [7.51$, 14.79$]
Financial Metrics affecting the NUS estimates:
- Positive: with PPE of 8.0 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: Operating cash flow per share per price, % of 33.18 > 13.24
- Positive: 41.86 < Shareholder equity ratio, % of 44.35 <= 63.39
- Negative: negative Net income
- Positive: 0 < Industry earnings per price (median), % of 0.38
- Positive: Industry inventory ratio change (median), % of -1.22 <= -0.15
- Positive: -8.75 < Industry operating profit margin (median), % of 1.21
- Negative: Investing cash flow per share per price, % of -11.27 <= -4.48
Short-term NUS quotes
Long-term NUS plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $2,225.66MM | $1,969.13MM | $1,732.08MM |
| Operating Expenses | $2,114.81MM | $1,920.86MM | $1,883.67MM |
| Operating Income | $110.85MM | $48.27MM | $-151.59MM |
| Non-Operating Income | $-21.88MM | $-21.69MM | $-23.47MM |
| Interest Expense | $13.49MM | $25.56MM | $26.41MM |
| Income(Loss) | $88.97MM | $26.58MM | $-175.05MM |
| Taxes | $-15.81MM | $17.98MM | $-28.46MM |
| Profit(Loss)* | $104.78MM | $8.60MM | $-146.59MM |
| Stockholders Equity | $897.30MM | $821.97MM | $651.46MM |
| Inventory | $346.18MM | $279.98MM | $190.24MM |
| Assets | $1,820.97MM | $1,808.63MM | $1,468.91MM |
| Operating Cash Flow | $108.06MM | $118.64MM | $111.74MM |
| Capital expenditure | $59.06MM | $58.49MM | $41.58MM |
| Investing Cash Flow | $-67.08MM | $-134.50MM | $-37.96MM |
| Financing Cash Flow | $-99.50MM | $10.73MM | $-133.18MM |
| Earnings Per Share** | $2.10 | $0.17 | $-2.95 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.